Insider filing
Traded Sep 9 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
101 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q1 2026 13F
182,047
272,174
+49.5%
Share count drives classification; reported value also moves with price
0.74%
Within the filing's reported positions, not the manager's total assets
101
For Q2 2026
Insider filing
Traded Sep 9 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Timothy Archer (President and CEO) sold ~$9.58M of Lam Research
Planned saleInsider filing
Traded Sep 9 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade. A share price line is a session where the close moved at least 10% and four times its usual daily change.
The company's last weighty Form 8-K report up to this date: reported its results, 16 days earlier (Jul 29, 2026). The first one after it: changed a top executive or board member, 10 days later (Aug 24, 2026).